Viewing nowCombinationEmpamax M Extended Release Tablet 10/1000 mg (Empagliflozin, Metformin)
Empagliflozin L-Proline 12.55mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.

MFDS item code 202501898 · Approved 2025.07.24 · Insurance code 643310000
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication helps effectively regulate blood glucose in patients with type 2 diabetes. It is especially suitable for adult patients who adhere to dietary and exercise regimens. It is particularly appropriate for patients whose blood glucose control is insufficient, and patients with cardiovascular disease must take it cautiously under medical supervision. This medication not only aids in blood glucose regulation but can also help prevent cardiovascular complications. Therefore, consistent use may assist in maintaining a healthy blood glucose status. It is used for blood glucose control in patients with type 2 diabetes.
For antidiabetic therapy, the dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin hydrochloride extended-release 2000 mg. This medicine should be taken once daily with the evening meal to reduce gastrointestinal adverse reactions caused by metformin. Patients taking this medicine as 10/1000 mg or 25/1000 mg extended-release tablets should take 1 tablet once daily. Patients taking this medicine as 12.5/1000 mg or 12.5/750 mg extended-release tablets should take 2 tablets together once daily. To reduce gastrointestinal adverse reactions associated with metformin use, the dose of metformin hydrochloride should be increased gradually. To maintain its extended-release properties, this medicine should be swallowed whole without splitting, crushing, grinding, or chewing. This medicine may not dissolve completely and may be excreted in the feces. It is not known whether the material excreted in the feces contains the active ingredient of the medicine. If a patient repeatedly reports finding this medicine in the feces, healthcare professionals should assess whether blood glucose is being adequately controlled (see Precautions for Use, 5. General Precautions). ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended initial total daily dose of this medicine is empagliflozin 10 mg and the patient's current metformin dose. If empagliflozin 10 mg is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg. ⦁ Patients switching from concomitant therapy with empagliflozin and metformin to this medicine should receive their current doses of empagliflozin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted as appropriate. ⦁ When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). Special Populations Renal Impairment Because dosage adjustment according to renal function is necessary, assessment of renal function is recommended before starting this medicine and periodically thereafter. No dosage adjustment of this medicine is necessary in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60 mL/min or estimated glomerular filtration rate (eGFR) ≧ 60 mL/min/1.73 m2]. In patients with moderate renal impairment [CKD stage 3A, creatinine clearance (CrCl) ≧ 45 mL/min and < 60 mL/min or estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73m2 and < 60 mL/min/1.73m2] who tolerate treatment well and do not have other conditions that may increase the risk of lactic acidosis, this medicine may be used with metformin hydrochloride dose adjustment as follows. - Because the starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000 mg. If creatinine clearance (CrCl) decreases to less than 45 mL/min or estimated glomerular filtration rate (eGFR) decreases to less than 45 mL/min/1.73m2, this medicine should be discontinued immediately. Elderly Patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication helps lower blood glucose and is used in the treatment of diabetes. One of the most important precautions when taking this medication is the possibility of rare side effects like lactic acidosis. Lactic acidosis can cause a serious condition due to excessive accumulation of lactic acid in the body, so if symptoms such as muscle pain, shortness of breath, lethargy, or abdominal pain appear, immediate consultation with a physician is essential. Furthermore, taking this medication in conjunction with other diabetes medications such as insulin or sulfonylureas may increase the risk of hypoglycemia, hence careful monitoring of blood sugar levels is necessary. Patients with impaired kidney function, serious health issues such as acute infections, dehydration, heart failure, or acute myocardial infarction should not use this medication, and those scheduled for surgery should discontinue use 48 hours prior to the procedure. Additionally, this medication is not recommended for patients with poor liver function, severe pulmonary disease, or those with excessive alcohol consumption. Regular kidney function tests should be conducted during treatment, particularly for elderly patients or those with compromised kidney function, and frequency of testing should be increased. Temporary discontinuation of this medication is required before and after tests using iodinated contrast agents, and it can be resumed once kidney function is confirmed to be normal. This medication may increase the risk of genital and urinary tract infections, so immediate treatment is necessary if symptoms of infection occur. There may be a risk of vitamin B12 deficiency, hence patients on prolonged treatment should have their vitamin B12 levels checked regularly. It is advised that women who are pregnant, potentially pregnant, or breastfeeding do not use this medication. Moreover, its safety and efficacy in children under the age of 18 have not been established, so it should not be administered to this age group. Elderly patients are at risk for dehydration and impaired kidney function; therefore, caution is needed during use, and regular kidney function tests are essential. In case of overdose, there is a risk of lactic acidosis, requiring immediate medical attention. This medication should be swallowed whole and should not be crushed or chewed, and it is normal for the coating to be excreted in the stool. Patients should avoid alcohol consumption while on this medication, and regular meals should not be skipped to prevent hypoglycemic symptoms. Lastly, there may be interactions with other medications being taken concurrently, so it is fundamental to inform healthcare providers about all current medications.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1°C and 30°C at room temperature. Proper storage will help maintain the drug's efficacy and safety.
Pale pink oval extended-release film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin L-Proline 12.55mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 15.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 15.7mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Chong Kun Dang
CombinationEmpagliflozin L-Proline 15.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jonggeun Dang Co., Ltd.
CombinationEmpagliflozin L-Proline 6.28mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 6.28mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 6.28mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 31.38mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.